Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan.

BMC genomics - 11 Nov 2024

Chhoung Chanroth, Ko Ko, Ouoba Serge, Phyo Zayar, Akuffo Golda Ataa, Sugiyama Aya, Akita Tomoyuki, Sasaki Hiroshi, Yamamoto Tadashi, Takahashi Kazuaki, Tanaka Junko

Abstract excerpt

BACKGROUND: The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persists, giving rise to new variants characterized by mutations in the spike protein. However, public data regarding the virus's evolutionary trend is not widely available after the downgrade of coronavirus disease 2019(COVID-19). Therefore, this study aimed to investigate the applicability of an in-house Sanger-based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to Genome, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Phylogeny

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 39528931
DOI: 10.1186/s12864-024-10973-0
PMCID: PMC11552212

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan.PMID 39528931Read ↗

Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima.Semantic proximity Read ↗

SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: genomic surveillance in Japan from September 2021 to March 2022Semantic proximity Read ↗

SARS-CoV-2 B.1.1.7 lineage rapidly spreads and overwhelms R.1 lineage in Japan: serial and stationary observation in a communitySemantic proximity Read ↗

Molecular Epidemiology of SARS-CoV-2 Genome Sentinel Surveillance in Commercial COVID-19 Testing Sites Targeting Asymptomatic Individuals During Japan’s Seventh Epidemic WaveSemantic proximity Read ↗

Molecular epidemiological features of SARS-CoV-2 in Japan, 2020–1Semantic proximity Read ↗

Molecular epidemiology of SARS-CoV-2 genome sentinel surveillance in commercial COVID-19 testing sites targeting asymptomatic individuals during Japan’s seventh epidemic waveSemantic proximity Read ↗

Comprehensive genomic analysis of the SARS-CoV-2 Omicron variant BA.2.76 in Jining City, China, 2022Semantic proximity Read ↗

Tracking SARS-CoV-2 variants by entire S-gene analysis using long-range RT-PCR and Sanger sequencing.Semantic proximity Read ↗

Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan.Semantic proximity Read ↗

[Genomic Characterization of SARS-CoV-2 by Next-Generation Sequencing Analysis].Semantic proximity Read ↗

Monitoring the spread of SARS-CoV-2 variants in Moscow and the Moscow region using targeted high-throughput sequencingSemantic proximity Read ↗

SARS-CoV-2 R.1 lineage variants that prevailed in Tokyo in March 2021.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.